1. Home
  2. SCLX vs SLND Comparison

SCLX vs SLND Comparison

Compare SCLX & SLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$9.03

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Logo Southland Holdings Inc.

SLND

Southland Holdings Inc.

HOLD

Current Price

$1.71

Market Cap

100.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
SLND
Founded
2011
1900
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
90.0M
100.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SCLX
SLND
Price
$9.03
$1.71
Analyst Decision
Hold
Hold
Analyst Count
1
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
80.8K
126.8K
Earning Date
11-14-2025
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,360,000.00
$935,461,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$749.70
$0.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.60
$1.63
52 Week High
$34.27
$5.34

Technical Indicators

Market Signals
Indicator
SCLX
SLND
Relative Strength Index (RSI) 34.71 27.45
Support Level $7.82 $1.77
Resistance Level $10.41 $1.95
Average True Range (ATR) 1.02 0.27
MACD 0.05 -0.04
Stochastic Oscillator 20.56 11.10

Price Performance

Historical Comparison
SCLX
SLND

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.

Share on Social Networks: